Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prospective analysis of nonadherence in autoimmune hepatitis: a common problem.

Kerkar N, Annunziato RA, Foley L, Schmeidler J, Rumbo C, Emre S, Shneider B, Shemesh E.

J Pediatr Gastroenterol Nutr. 2006 Nov;43(5):629-34.

PMID:
17130740
2.

A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients.

Shemesh E, Lurie S, Stuber ML, Emre S, Patel Y, Vohra P, Aromando M, Shneider BL.

Pediatrics. 2000 Feb;105(2):E29.

PMID:
10654989
3.

Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.

Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, Buts JP, Sokal E.

Transplantation. 2001 Jul 27;72(2):267-72.

PMID:
11477351
4.

Medication adherence in pediatric and adolescent liver transplant recipients.

Shemesh E, Shneider BL, Savitzky JK, Arnott L, Gondolesi GE, Krieger NR, Kerkar N, Magid MS, Stuber ML, Schmeidler J, Yehuda R, Emre S.

Pediatrics. 2004 Apr;113(4):825-32.

PMID:
15060234
5.

Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients.

Shemesh E, Annunziato RA, Yehuda R, Shneider BL, Newcorn JH, Hutson C, Cohen JA, Briere J, Gorman JM, Emre S.

J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1280-9.

PMID:
17885569
6.

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.

Miyake Y, Iwasaki Y, Terada R, Okamaoto R, Ikeda H, Makino Y, Kobashi H, Takaguchi K, Sakaguchi K, Shiratori Y.

Aliment Pharmacol Ther. 2006 Oct 15;24(8):1197-205.

7.

A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI).

Shemesh E, Rudnick A, Kaluski E, Milovanov O, Salah A, Alon D, Dinur I, Blatt A, Metzkor M, Golik A, Verd Z, Cotter G.

Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):215-22.

PMID:
11543848
8.

Childhood autoimmune liver disease: indications and outcome of liver transplantation.

Chai PF, Lee WS, Brown RM, McPartland JL, Foster K, McKiernan PJ, Kelly DA.

J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):295-302. doi: 10.1097/MPG.0b013e3181bf0ef7.

PMID:
20118802
9.

Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation.

Dew MA, Dabbs AD, Myaskovsky L, Shyu S, Shellmer DA, DiMartini AF, Steel J, Unruh M, Switzer GE, Shapiro R, Greenhouse JB.

Transplantation. 2009 Sep 15;88(5):736-46. doi: 10.1097/TP.0b013e3181b2a0e0.

10.

Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.

Dhaliwal HK, Anderson R, Thornhill EL, Schneider S, McFarlane E, Gleeson D, Lennard L.

Hepatology. 2012 Oct;56(4):1401-8. doi: 10.1002/hep.25760. Epub 2012 Sep 7.

PMID:
22488741
11.

Adherence in liver transplant recipients.

Burra P, Germani G, Gnoato F, Lazzaro S, Russo FP, Cillo U, Senzolo M.

Liver Transpl. 2011 Jul;17(7):760-70. doi: 10.1002/lt.22294. Review.

12.

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.

Miyake Y, Iwasaki Y, Terada R, Takagi S, Okamaoto R, Ikeda H, Sakai N, Makino Y, Kobashi H, Takaguchi K, Sakaguchi K, Shiratori Y.

J Hepatol. 2005 Dec;43(6):951-7. Epub 2005 Jul 7.

PMID:
16143423
13.

Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.

Nguyen TM, Daubard M, Le Gall C, Larger M, Lachaux A, Boulieu R.

Ther Drug Monit. 2010 Aug;32(4):433-7. doi: 10.1097/FTD.0b013e3181dbd712.

PMID:
20479703
14.

Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report.

Rumbo C, Emerick KM, Emre S, Shneider BL.

J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):391-8.

PMID:
12352536
15.

Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.

Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, Strassburg CP, Pröls M, Woźniak M, Manns MP; European Autoimmune Hepatitis-Budesonide Study Group.

J Pediatr. 2013 Nov;163(5):1347-53.e1. doi: 10.1016/j.jpeds.2013.05.042. Epub 2013 Jun 28.

PMID:
23810723
16.

Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.

Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C.

J Hepatol. 2015 Mar;62(3):642-6. doi: 10.1016/j.jhep.2014.10.018. Epub 2014 Oct 18.

PMID:
25457202
17.

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

Alvarez F, Ciocca M, Cañero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, Gonzalez T, Jara-Vega P, Camarena C, Brochu P, Drut R, Alvarez E.

J Hepatol. 1999 Feb;30(2):222-7.

PMID:
10068099
18.

Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors.

Sockalingam S, Blank D, Abdelhamid N, Abbey SE, Hirschfield GM.

J Hepatol. 2012 Dec;57(6):1299-304. doi: 10.1016/j.jhep.2012.07.032. Epub 2012 Aug 4.

PMID:
22871503
19.

Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients.

Bellomo-Brandão MA, Costa-Pinto EA, De Tommaso AM, Hessel G.

Arq Gastroenterol. 2006 Jan-Mar;43(1):45-9. Epub 2006 May 8.

20.

Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction.

Shemesh E, Yehuda R, Milo O, Dinur I, Rudnick A, Vered Z, Cotter G.

Psychosom Med. 2004 Jul-Aug;66(4):521-6.

PMID:
15272097

Supplemental Content

Support Center